DaVita Inc. Common Stock (DVA): Upgrade News

DVA – Raymond James raises to strong buy. Stock price at the time of this analyst call was $69.20.


Update: As of Dec. 13, 2017, this bullish analyst call has returned 1.63%.


Key Facts Surrounding This News Item


  • DVA had a POWR Rating of A (Strong Buy) coming into today.
  • DVA was 14.59% above its 10-Day Moving Average coming into today.
  • DVA was 20.05% above its 20-Day Moving Average coming into today.
  • DVA was 18.48% above its 50-Day Moving Average coming into today.
  • DVA was 17.34% above its 100-Day Moving Average coming into today.
  • DVA was 10.29% above its 200-Day Moving Average coming into today.
  • DVA had returned +7.79% year-to-date leading up to today’s news, versus a +19.44% return from the benchmark S&P 500 during the same period.

More Info About DaVita Inc. Common Stock (DVA)


DaVita Healthcare Partners delivers dialysis services to patients with chronic kidney failure and end stage renal disease. The company was founded in 1994 and is based in Denver, Colorado. View our full DVA ticker page with ratings, news, and more.

DVA at a Glance

DVA Current POWR Rating™
Overall POWR Rating™
DVA Current Price $70.33 0.10%
More DVA Ratings, Data, and News

DVA Price Reaction

The day of this event (Dec. 7, 2017)
DVA Closing Price$67.14 2.98%
DVA Volume4,089,200
149.31% from avg
Leading up to this event
DVA 1-mo return17.37%
After this event
DVA 1-day return2.20%
DVA 3-day return1.70%

DVA Price Chart



More DaVita Inc. Common Stock (DVA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All DVA News
Page generated in 0.8846 seconds.